1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
167 | / |
2026 |
|
||||||
Date of issue: |
2026-06-09 |
||||||||||
Short name of the issuer |
|||||||||||
SOPHARMA AD |
|||||||||||
Subject |
|||||||||||
Notification for sale of treasury shares |
|||||||||||
Official market - legal basis |
|||||||||||
Art. 56. 1. 2 of Act on Public Offering |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
Sofia, Bulgaria, June 09, 2026 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 08, 2026 the Company sold 21 000 (twenty-one thousand) treasury shares representing 0.004% of the share capital of the Company, at a total value of EUR 39 725.01 on the Bulgarian Stock Exchange, the average price per share was EUR 1.89. The total number of treasury shares after this transaction is 8 455 300 representing 1.57% of the share capital of the Company. |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Notification for sale of treasury shares |
|||||||||||
SOPHARMA AD |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
SOPHARMA AD |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
1220 |
Sofia |
||||||||||||
(post code) |
(city) |
||||||||||||
IlienskoShosse |
16 | ||||||||||||
(street) |
(number) |
||||||||||||
+359 2 813 42 00 |
+359 2 936 02 86 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nd |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2026-06-09 |
Ognian Ivanov Donev |
Executive Director |
|||
